We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Cannabis Used by Up to a Quarter of Cancer Patients

By HospiMedica International staff writers
Posted on 05 Oct 2017
Print article
A new study reports that approximately 25% of cancer patients used marijuana in the past year, mostly for physical and psychological symptoms.

Researchers at Fred Hutchinson Cancer Research Center (Seattle, WA, USA) and the University of Washington (UW; Seattle, USA) conducted a cross-sectional survey among 926 patients (median age 58 years) in order to determine the prevalence and methods of use, perceived benefits, and the sources of information on cannabis for medical use; random urine samples for tetrahydrocannabinol provided survey validation. The study was conducted in Washington State, which has legalized marijuana for medicinal and recreational use.

The results revealed that a majority of the patients had a strong interest in learning about cannabis during treatment and wanted information from cancer providers. Previous use was common (66%), with 24% using cannabis in the last year, 21% using cannabis in the last month, and 18% using during the previous week, a percentage similar to that found in the random urine samples (14%). Cannabis use was primarily for physical (75%) and neuropsychiatric symptoms (63%). Legalization significantly increased the likelihood of use in more than half of the respondents. The study was published on September 25, 2017, in Cancer.

“Cancer patients desire but are not receiving information from their cancer doctors about marijuana use during their treatment, so many of them are seeking information from alternate non-scientific sources,” said lead author Steven Pergam, MD, MPH. “We hope that this study helps to open up the door for more studies aimed at evaluating the risks and benefits of marijuana in this population… because if we do not educate our patients about marijuana, they will continue to get their information elsewhere.”

Marijuana is the name given to the dried buds and leaves of varieties of the Cannabis sativa plant, and has been used in herbal remedies for centuries. The two most active components in marijuana are delta-9-tetrahydrocannabinol (THC), and cannabidiol (CBD). THC seems to cause the "high" reported by users, and also can help relieve pain and nausea and reduce inflammation. CBD can help treat seizures, reduce anxiety and paranoia, and counteract the THC high. Eight U.S. states and the District of Columbia have legalized recreational marijuana, and over half of U.S. states have passed laws allowing for medical marijuana in some form.

Related Links:
Fred Hutchinson Cancer Research Center
University of Washington
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Non-Contact Infrared Forehead Thermometer
Propper IR Thermometer

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.